Lung cancer wonder drug hailed as study shows ‘off the chart’ survival benefit
Results from a trial of daily pill lorlatinib were described as “unprecedented”.
Daily Express :: Health Feed
Results from a trial of daily pill lorlatinib were described as “unprecedented”.
Daily Express :: Health Feed